What are the odds that a bee or wasp sting will trigger anaphylactic shock requiring an epinephrine injection?
Evidence quality 4.25/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 4/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 4/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 4/5
- D6 Prose
- 4/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, US adult
1 in 50
2.0% lifetime chance
range 1 in 100 to 1 in 25
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
Anaphylaxis from a sting has an unusual perception profile: people who carry an epinephrine auto-injector know their precise risk and tend to hold it accurately, while most people who have never reacted assume their lifetime "been stung before, was fine" record makes them essentially safe. The evidence does not support that second reading: roughly half of all fatal sting reactions in the US occur in people with no prior history of a systemic allergic response.
Rough estimate: non-allergic adults tend to guess near-zero personal risk; the actual lifetime rate is roughly 1 in 50 for severe reactions
Source: editorial intuition, not polled
Actual
~3% of US adults report a systemic allergic reaction to a sting in their lifetime
US adults
Show derivation
Golden (Immunology and Allergy Clinics of North America, 2007, PMC1961691) and the ACAAI both report that systemic allergic reactions to stings occur in approximately 3% of US adults over their lifetime. The 3% figure (≈7.8M of 260M adults) is the widest defensible numerator — it includes urticaria-only systemic responses in addition to full cardiovascular or respiratory anaphylaxis. The sub-fraction that meets the stricter clinical definition of anaphylaxis (Grade III–IV Müller: hypotension, bronchospasm, or loss of consciousness, requiring epinephrine) is approximately two-thirds of adult systemic reactions, yielding a lifetime probability of roughly 2% (~1 in 50). The normalized value of 0.02 is used because the question specifically asks about epinephrine-requiring anaphylaxis rather than urticaria-only reactions. Uncertainty bounds bracket the full 3% ceiling and a conservative 1% floor corresponding to diagnosed venom allergy prevalence.
Caveats: The 3% lifetime figure covers all systemic sting reactions in US adults, includi…
The 3% lifetime figure covers all systemic sting reactions in US adults, including milder urticaria-only episodes that may not require epinephrine. Strict cardiovascular/respiratory anaphylaxis (the scenario where an epi-pen is genuinely life-saving) is a sub-fraction, estimated here at ~2% lifetime. Risk is highly non-uniform: individuals with prior systemic reactions face a 25–70% chance of reacting again on re-sting, while those who have completed venom immunotherapy reduce their risk by ~95%. Notably, roughly half of all fatal sting reactions in the US occur in people with no prior history of systemic allergy — so a lifetime "never had a bad reaction" record does not eliminate risk, it just shifts one into the lower-risk portion of the population distribution.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Swallowed bee/wasp
What are the odds of accidentally swallowing a live bee or wasp and suffering a life-threatening airway reaction?
Bat bite & rabies
What are the odds of being exposed to a bat in a way that warrants rabies treatment?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
About 3% of US adults will experience a systemic allergic reaction to a bee or wasp sting at some point in their life — roughly 1 in 33. The subset that meets the clinical threshold for anaphylaxis (cardiovascular or respiratory involvement: hypotension, bronchospasm, or loss of consciousness) sits at roughly 2% lifetime, or about 1 in 50. These are not exotic numbers; for comparison, the lifetime probability of dying in a car crash is around 1 in 93, so sting-triggered anaphylaxis is in the same order of magnitude as one of the most-cited benchmark risks in everyday life.
What makes this fear tractable is that it has a highly effective treatment: epinephrine given promptly converts what would otherwise be a life-threatening event into one with very low fatality. The ~220,000 annual US emergency department visits for sting allergic reactions resolve with ~62 deaths per year — a case fatality rate around 0.03% among those who reach an ED. The gap between “systemic anaphylaxis event” and “death from it” is almost entirely explained by access to and timing of epinephrine. The practical implication for the roughly 1–2% of adults with a confirmed venom allergy is straightforward: carrying a prescribed auto-injector and knowing how to use it transforms the risk profile substantially.
A finding worth flagging: per the allergy literature, roughly half of fatal sting reactions in the US occur in people with no prior history of a systemic allergic response. This does not mean the average person should carry an epi-pen — the absolute risk per sting for a non-allergic adult is still very small — but it does mean that a lifetime record of uneventful stings is not a reliable signal of permanent safety. First systemic reactions can and do occur in middle age and beyond, with no warning from prior sting tolerance. Anyone who develops more than local swelling after a sting warrants allergy evaluation.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] Immunology and Allergy Clinics of North America (Golden DBK) / PubMed Central — Insect Sting Anaphylaxis
Insect Sting AnaphylaxisSee all 2 Likelier entries citing this source →
- Statistic
Systemic allergic reactions reported by up to 3% of US adults; ≥50 fatal sting reactions per year; ~half of fatal reactions occur with no prior history- Excerpt
“"Systemic allergic reactions are reported by up to 3% of adults, and almost 1% of children have a medical history of severe sting reactions … At least 50 fatal sting reactions occur each year in the United States … Half of all fatal reactions occur with no history of previous sting reactions." ”
- Source data from
- 2007-05-01
- Accessed
- 2026-05-04 · archived copy
- Calculation
- Primary source for the 3% lifetime systemic reaction prevalence. The normalized value of 0.02 uses the ~2/3 severe-within-systemic fraction (Grade III–IV, epi-requiring) to arrive at a ~2% lifetime probability.
- Independence
- Draws from clinical allergy and venom-IgE serology literature, independent of death-certificate or NEISS ED-visit data streams.
-
[2] American Academy of Family Physicians / American Family Physician — Stinging Insect Allergy
Stinging Insect Allergy- Statistic
1–3% of adults experience systemic reactions to insect stings; ~220,000 sting allergic reaction ED visits per year in the US- Excerpt
“"Between 1 and 3 percent of the general population has a history of systemic allergic reactions to insect stings … In the United States, approximately 220,000 emergency department visits occur annually for insect sting allergic reactions … The mortality rate is estimated at 40 deaths per year, but this is likely an underestimate." ”
- Source data from
- 2003-06-15
- Accessed
- 2026-05-04 · archived copy
- Calculation
- Corroborates the 1–3% lifetime systemic reaction range and provides the 220,000/year ED visit baseline. The annual visit rate cross-checks the lifetime prevalence: 220,000 / 335,000,000 ≈ 6.6 × 10^-4/year, compounded over 59 years ≈ 3.8% — consistent with the top of the 3% lifetime range when ED-seeking behavior is factored in.
- Independence
- AAFP review drawing on epidemiological literature independent of the Golden 2007 PMC source above.